Allopurinol
Vasodilation
The University of Texas at ArlingtonSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Vasodilation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tadalafil University of Florida | Phase 2 | CCC |
METHOTREXATE The University of Texas at Arlington | Phase 1 | CC |
MERCAPTOPURINE ANHYDROUS The University of Texas at Arlington | Phase 1 | CC |
Apocynin The University of Texas at Arlington | Phase 1 | CC |
4-OXYPIPERIDOL The University of Texas at Arlington | Phase 1 | CC |
View all 18 →
Same molecule, other indications
Allopurinol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →